262 related articles for article (PubMed ID: 16213152)
1. Modern diagnostics in acute leukemias.
Haferlach T; Kern W; Schnittger S; Schoch C
Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.
Rizzari C; Cazzaniga G; Coliva T; De Angelis C; Conter V
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313
[TBL] [Abstract][Full Text] [Related]
4. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
5. [Minimal residual disease in childhood acute leukemias].
Pawińska K; Balwierz W; Baran J
Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease as a surrogate marker for risk assignment to ALL patients.
Cazzaniga G; Gaipa G; Rossi V; Biondi A
Rev Clin Exp Hematol; 2003 Sep; 7(3):292-323. PubMed ID: 15024971
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
8. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
Al-Mawali A; Gillis D; Lewis I
Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of minimal residual disease in acute myeloid leukemia.
Kern W; Schoch C; Haferlach T; Schnittger S
Crit Rev Oncol Hematol; 2005 Nov; 56(2):283-309. PubMed ID: 16213150
[TBL] [Abstract][Full Text] [Related]
10. [Multidisciplinary diagnostics in acute leukemia].
Hokland P; Pedersen B; Bendix K; Koch JE; Pallisgaard N
Ugeskr Laeger; 1998 Sep; 160(38):5473-8. PubMed ID: 9763918
[TBL] [Abstract][Full Text] [Related]
11. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
Bacher U; Kern W; Schoch C; Schnittger S; Hiddemann W; Haferlach T
Cancer; 2006 Feb; 106(4):839-47. PubMed ID: 16419072
[TBL] [Abstract][Full Text] [Related]
13. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
Haferlach T; Kern W; Schnittger S; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
[TBL] [Abstract][Full Text] [Related]
14. 10-Parameter flow cytometry as a new tool to improve diagnosis and MRD follow-up of acute leukemias.
Wehner S; Soerensen J; Schwabe D; Tramsen L; Quaritsch R; Esser R; Klingebiel T; Koehl U
Klin Padiatr; 2009; 221(6):393-5. PubMed ID: 19890796
[No Abstract] [Full Text] [Related]
15. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
Borowitz MJ; Pullen DJ; Winick N; Martin PL; Bowman WP; Camitta B
Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and genetic subtypes of leukemia combining gene expression and flow cytometry.
Basso G; Case C; Dell'Orto MC
Blood Cells Mol Dis; 2007; 39(2):164-8. PubMed ID: 17588788
[TBL] [Abstract][Full Text] [Related]
17. Role of gene expression profiling for diagnosing acute leukemias.
Kern W; Kohlmann A; Schnittger S; Schoch C; Haferlach T
Rev Clin Exp Hematol; 2005 Jun; 9(1):E1. PubMed ID: 16027103
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnostics in acute leukemias.
Bacher U; Schnittger S; Haferlach C; Haferlach T
Clin Chem Lab Med; 2009; 47(11):1333-41. PubMed ID: 19817644
[TBL] [Abstract][Full Text] [Related]
19. Acute lymphoblastic leukemia with 4;11 translocation analyzed by a multi-modal strategy of conventional cytogenetics, FISH, morphology, flow cytometry and molecular genetics, and review of the literature.
Hayne CC; Winer E; Williams T; Chaves F; Khorsand J; Mark HF
Exp Mol Pathol; 2006 Aug; 81(1):62-71. PubMed ID: 16765346
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of minimal residual disease in acute myeloid leukemia.
Kern W; Haferlach C; Haferlach T; Schnittger S
Cancer; 2008 Jan; 112(1):4-16. PubMed ID: 18000811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
